TORONTO -- Blood tests for Alzheimer's disease biomarkers can be used clinically -- and can replace expensive brain scans and ...

A pair of FDA-approved cancer drugs may help reverse the biological changes that drive Alzheimer’s disease, according to a ...

Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new ...

The idea that herpes infections trigger or contribute to Alzheimer's disease has been gaining favor among some scientists, ...

A major Alzheimer’s disease medical group is recommending that specialists may use certain blood tests to help diagnose ...

Blood-based biomarker testing can be used to diagnose Alzheimer’s disease but must have a significantly high degree of ...

A study that compared the gene expression profile of Alzheimer's disease with those triggered by 1,300 approved drugs identified a combination of two cancer medications as a potential treatment for ...

A NEW “game-changing” drug could stop the progression of Alzheimer’s disease, early trials suggest. Scientists say the treatment – called trontinemab – could be the ...

It takes an average of 3.5 years to diagnose patients with dementia following their first symptoms, according to researchers.

Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related dementia (ADRD), sparking hope for potential interventions to prevent the ...

The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that slow progression of the disease is drastically improving outcomes for patients ...

Reduced cognitive function is a normal part of aging. Age-related changes often include getting confused about the day of the ...